DJ Affluent Medical: Coverage initiation by Kepler Cheuvreux.
Affluent Medical Affluent Medical: Coverage initiation by Kepler Cheuvreux. 14-Apr-2022 / 17:55 CET/CEST Dissemination of a French Regulatory News, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.
-----------------------------------------------------------------------------------------------------------------------
PRESS RELEASE
Aix-en-Provence, 14 April 2022 - 17:45
Coverage initiation by Kepler Cheuvreux
Affluent Medical (ISIN code: FR0013333077 - Ticker: AFME), a French medtech specialising in the international development and industrialisation of innovative medical prostheses, at a clinical stage, to treat urinary incontinence and mitral valve pathology, announces today that Kepler Cheuvreux has initiated coverage of the stock.
Affluent Medical now benefits from Kepler Cheuvreux' coverage with the publication of a financial note entitled " Kill three birds with one stone". This new note completes the coverage of the stock and enriches the consensus of analysts alongside Swisslife and Invest Securities. The financial analysis is available on the website: https:// www.keplercheuvreux.com/, under "Research Public Access".
About Affluent Medical
Affluent Medical is a French player in MedTech, founded by Truffle Capital, with the aim of becoming a global leader in the treatment of heart and vascular diseases, which are the leading cause of death worldwide, and of urinary incontinence, which today affects one in four adults. Affluent Medical develops innovative, next-generation minimally invasive implants to restore essential physiological functions in these areas. The four major technologies developed by the Company are currently in the pre-clinical and clinical study phase. Kalios is set to be the first medical device to be marketed in Europe.
For more information, please visit: www.affluentmedical.com
Contacts:
AFFLUENT MEDICAL ACTIFIN, financial communication
Jérôme GEOFFROY Ghislaine GASPARETTO
Chief Financial and Administrative Officer +33 (0) 6 21 10 49 24
investor@affluentmedical.com affluentmedical@actifin.fr
ACTIFIN, financial press relations
Jennifer JULLIA PRIMATICE, public relations France
Thomas ROBOREL de CLIMENS
+33 (0) 6 47 97 54 87 +33 (0) 6 78 12 97 95
jjullia@actifin.fr thomasdeclimens@primatice.com
-----------------------------------------------------------------------------------------------------------------------
Regulatory filing PDF file File: Affluent Medical - Kepler Cheuvreux EN
=------------------------------------------------------------------
Language: English
Company: Affluent Medical
320 avenue Archimède, Les pléiades III Bâtiment B
13100 Aix en Provence France
France
Phone: +33 4 42 95 12 20
E-mail: jerome.geoffroy@affluentmedical.com
Internet: https://www.affluentmedical.com/
ISIN: FR0013333077
Euronext Ticker: AFME
AMF Category: Inside information / Other releases
EQS News ID: 1328901
End of Announcement EQS News Service
=------------------------------------------------------------------------------------
1328901 14-Apr-2022 CET/CEST
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1328901&application_name=news
(END) Dow Jones Newswires
April 14, 2022 11:55 ET (15:55 GMT)
